Publication | Closed Access

UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients

Viral HepatitisBioanalysisUplc–ms/ms MethodAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapySofosbuvir MetaboliteClinical ChemistryHivAntiviral DrugMedicineChronic Viral InfectionSimultaneous QuantificationDrug Analysis